NCT03843944View on ClinicalTrials.gov

Overnight Switch From Rasagiline To Safinamide

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

March 31, 2019

Study Completion Date

May 31, 2019

Conditions
Parkinson Disease
Interventions
DRUG

Safinamide

Overnight switch from rasagiline 1 mg OD to safinamide 50 mg OD

Trial Locations (1)

00163

IRCCS San Raffaele, Roma

All Listed Sponsors
lead

IRCCS San Raffaele Roma

OTHER

NCT03843944 - Overnight Switch From Rasagiline To Safinamide | Biotech Hunter | Biotech Hunter